710 likes | 842 Vues
The HIV and Hepatitis Workshop emphasizes the critical need to treat HIV/HCV coinfected patients, as Hepatitis C (HCV) affects approximately 25-40% of HIV-positive individuals in the U.S. Coinfection leads to more severe complications and progression of HCV, making it a significant health concern within the HIV population. HCV has emerged as one of the leading causes of morbidity and mortality among those living with HIV. Addressing HCV in these patients is essential for improving overall health outcomes and reducing mortality rates.
E N D